News item
Today, the Canadian Cancer Society publicly announced its $450,000 Innovation to Impact Grant to one of BioCanRx’s founding investigator, Dr. Rebecca Auer. The grant will support Dr. Auer’s research in investigating whether oncolytic virus vaccines and other immune-boosting therapies can stop cancer from spreading after surgery.
Source: http://www.cancer.ca/en/about-us/for-media/media-releases/national/2015/rebecca-auer-innovation-grant/?region=on&utm_source=Twitter&utm_medium=MediaRelease&utm_content=RebeccaAuer&utm_campaign=Research
